Abstract
Septic shock develops when specific microbial components gain access to the circulation and are recognized by the immune system, generating exaggerated mediator and cytokine production. The main microbial components responsible for this recognition are lipopolysaccharide (LPS) in Gram-negative bacteria, or peptidoglycan and teichoic acid in Gram-positive bacteria. Microbial compounds display molecular pattern recognition receptors (PRR) — such as LPS receptors (Toll-like receptor [TLR]4 and CD14) which are expressed constitutively on innate immune system cells (macrophages and dendritics cells) [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Medzhitov R, Janeway CA Jr (1997) Innate immunity: the virtues of a nonclonal system recognition. Cell 91: 295–298
Tokunaga T, Yamamoto H, Shimada S, et al (1984) Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst 72: 955–962
Krieg AK, Yi A-K, Matson S, et al (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374: 546–549
Krieg AM, Wu T, Weeratna R, et al (1998) Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci USA 95: 12631–12636
Häcker H, Mischak H, Miethke T, et al (1998) CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J 17: 6230–6240
Karlin S, Doerfler W, Cardon LR (1994) Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses? J Virol 68: 2889–2897
Krieg AM, Yi AK, Schorr J, Davis HL (1998) The role of CpG dinucleotides in DNA vaccines. Trends Microbiol 6: 23–27
Krieg AM (1996) An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA. J Lab Clin Med 128: 128–133
Hemmi H, Takeuchi O, Kawai T, et al (2000) A toll-like receptor recognizes bacterial DNA. Nature 408: 740–745
Krieg AM, Hartmann G, Yi AK (2000) Mechanism of action of CpG DNA. Curr Top Microbiol Immunol 247: 1–21
Yamamoto S, Yamamoto T, Shimada S, et al (1992) DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol Immunol 36: 983–997
Krieg AM (2001) Immune effects and mechanisms of action of CpG motifs. Vaccine 19: 618–622
Krieg AM (2001) From bugs to drugs: therapeutic immunomodulation with oligodeoxynucleotides containing CpG sequences from bacterial DNA. Antisense Nucleic Acid Drug Dev 11: 181–188
Weighardt H, Feterowski C, Veit M, Rump M, Wagner H, Holzmann B (2000) Increased resistance against acute polymicrobial sepsis in mice challenged with immunostimulatory CpG oligodeoxynucleotides is related to an enhanced innate effector cell response. J Immunol 165: 4537–4543
Medzhitov R, Janeway C Jr (2000) Innate immunity. N Engl J Med 343: 338–344
Hoshino K, Takeuchi O, Kawai T, et al (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162: 3749–3752
Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC (1990) CD14, a receptor for complexes of lipopolysaccharide ( LPS) and LPS binding protein. Science 249: 1431–1433
Shimazu R, Akashi S, Ogata H, et al (1999) MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 189: 1777–1782
Beltinger C, Saragovi HU, Smith RM, et al (1995) Binding, uptake, and intracellular trafficking of phosphothioate-modified oligodeoxynucleotides. J Clin Invest 95: 1814–1823
Hanss B, Stein CA, Klotman PE (1998) Cellular uptake and biodistribution of oligodeoxynucleotides. In: Stein CA, Krieg AM (eds) Applied Oligonucleotide Technology. John Wiley and Sons, Inc, New York, pp 431–448
Bennett RM, Gabor GT, Merritt MM (1985) DNA binding to human leukocytes. Evidence for a receptor-mediated association, internalization, and degradation of DNA. J Clin Invest 76: 2182–2190
Yi AK, Tuetken R, Redford T, Kirsch J, Krieg AM (1998) CpG motifs in bacterial DNA activates leukocytes through the pH-dependent generation of reactive oxygen species. J Immunol 160: 4755–4761
Zhao Q, Matson S, Herrera CJ, et al (1993) Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res Dev 3: 53–66
Häcker H (2000) Signal transduction pathways activated by CpG-DNA. Curr Top Microbiol Immunol 247: 77–92
Yi AK, Klinman DM, Martin TL, Matson S, Krieg AM (1996) Rapid immune activation by CpG motifs in bacterial DNA: systemic induction of IL-6 transcription through an anti-oxidant-sensitive pathway. J Immunol 157: 5394–5402
Stacey KJ, Sweet MJ, Hume DA (1996) Macrophages ingest and are activated by bacterial DNA. J Immunol 157: 2116–2122
Sparwasser T, Miethke T, Lipford G, et al (1997) Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-a-mediated shock. Eur J Immunol 27: 1671–1679
Yi AK, Krieg AM (1998) Rapid induction of mitogen activated protein kinases by immune stimulatory CpG DNA. J Immunol 161: 4493–4497
Krieg AM (2000) Signal transduction induced by immunostimulatory CpG DNA. Springer Semin Immunopathol 22: 97–105
Lewis TS, Shapiro PS, Ahn NG (1998) Signal transduction through MAP kinases cascades. Adv Cancer Res 74: 49–139
Baldwin As Jr (1996) The NF-KB and I-KB proteins: New discoveries and insights. Annu Rev Immunol 14: 649–681
Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z (1997) MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7: 837–847
Baeuerle PA, Henkel T (1994) Function and activation of NF-KB in the immune system. Annu Rev Immunol 12: 141–179
Brennan P, O’Neil L (1995) Effects of oxidants and antioxydants on NF-KB activation in three different cell lines: evidence against a universal hypothesis involving oxygen radicals. Biochem Biophys Acta 1260: 1670–1675
Yi AK, Chang M, Peckham DW, Krieg AM, Ashman RF (1998) CpG oligodeoxynucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle reentry. J Immunol 160: 4755–4761
Cowdery JS, Chace JH, Yi AK, Krieg AM (1996) Bacterial DNA induces NK cells to produce interferon-y in vivo and increases the toxicity of lipopolysaccharides. J Immunol 156: 45704575
Stacey KJ, Sester DP, Sweet MJ, Hume DA (2000) Macrophage activation by immunostimulatory DNA. Curr Top Microbiol Immunol 247: 41–58
Klinman D, Yi AK, Beaucage SL, Conover J, Krieg AM (1996) CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12 and IFNy. Proc Natl Acad Sci USA 93: 2879–2883
Lipford GB, Sparwasser T, Bauer M, et al (1997) Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines. Eur J Immunol 27: 3420–3426
Sparwasser T, Miethke T, Lipford G, et al (1997) Bacterial DNA causes septic shock. Nature 386: 336–337
Jakob T, Walker PS, Krieg AM, Udey MC, Vogel JC (1998) Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: A role for dendritic cells in the augmentation of Thl responses by immunostimulatory DNA. J Immunol 161: 3042–3049
Hartmann G, Krieg AM (1999) CpG DNA and LPS induce distinct patterns of activation in human monocytes. Gene Therapy 6: 893–903
Wang Z, Karras JG, Colarusso TP, Foote LC, Rothstein TL (1997) Unmethylated CpG motifs protect murine B lymphocytes against Fas-mediated apoptosis. Cell Immunol 180: 162–167
Lipford GB, Bauer M, Blank C, Reiter R, Wagner H, Heeg K (1997) CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants. Eur J Immunol 27: 2340–2344
Sun S, Zhang X, Tough DF, Sprent J (1998) Type I interferon-mediated stimulation of T cells by CpG DNA. J Exp Med 188: 2335–2342
Bendigs S, Salzer U, Lipford GB, Wagner H, Heeg K (1999) CpG-oligodeoxynucleotides costimulate primary T cells in the absence of APC. Eur J Immunol 29: 1209–1218
Sweet MJ, Stacey KJ, Kakuda DK, Markovich D, Hume DA (1998) IFN-y primes macrophage responses to bacterial DNA. J Interferon Cytokines Res 18: 263–271
Poltorak A, He X, Smirnova I, et al (1998) Defective LPS signaling in C3H/HeJ and C57BL/ 10ScCr mice: mutations in T1r4 gene. Science 282: 2085–2088
Wiel E, Ban E, Lund. N, Riveau G, Vallet B (2001) CpG motifs are sensitizing agents for LPS in toxic shock model. Intensive Care Med 27 (suppl 2 ): S233 (Abst)
Pisetsky DS (1996) The immunologic properties of DNA. J Immunol 156: 421–423
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wiel, E., Lebuffe, G., Vallet, B. (2002). Bacterial CpG DNA in Septic Shock. In: Vincent, JL. (eds) Intensive Care Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-5551-0_35
Download citation
DOI: https://doi.org/10.1007/978-1-4757-5551-0_35
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-5553-4
Online ISBN: 978-1-4757-5551-0
eBook Packages: Springer Book Archive